Topical delgocitinib appears more effective than oral alitretinoin and is comparable to dupilumab for treating types of hand eczema, according to two separate studies.

A significant inverse association was observed among topical corticosteroid phobia and adherence to treatment among adults with chronic hand eczema.

Three eczema warriors share how support from loved ones and the community has helped them navigate the challenges of the skin ...

I have been dealing with eczema for as long as I can remember. In honor of Eczema Awareness Month, here are my favorite ...

Eczema is way more common than you think. Per Healthline, 1 in 10 people will develop eczema in their lifetime. Eczema is ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Other things you can do to help control your baby's eczema include: Avoid rough, scratchy fabrics Don't use soap Use gentle, fragrance-free laundry detergents Put mittens on little hands to prevent ...

The European Commission has approved the topical pan–Janus kinase inhibitors inhibitor delgocitinib for adults with moderate ...

A headteacher has defended his school’s hair policy labelled as strict after a boy with severe eczema was punished for his ...

LEO Pharma has presented late-breaking data on the DELTA FORCE trial for Anzupgo (delgocitinib) cream as a potential ...